Regenetech to Present at BIO-Europe Spring 2008

Regenetech(R), Inc., the tissue regeneration adult stem cell
company which has built upon NASA licensed technology, is pleased to
announce that it will be presenting and participating in partnering
meetings at BIO-Europe Spring in Madrid, Spain, 7 - 9 April 2008. Dr.
David Bonner, CEO of Regenetech will be presenting Regenetech´s
current initiatives and activities at the conference at 5:45 pm (local
time) on 8 April 2008.

Regenetech announced in October 2007 that it had achieved a
60-fold increase of adult stem cells through its cellXpansion(TM)
process, in addition to which it has recently signed two international
licenses for its cellXpansion(TM) technology with organisations in
Korea and Mexico. The BIO-Europe Spring event will be an opportunity
to further update the industry on the exciting developments in the
Company´s technology.

Dr. David Bonner, CEO of Regenetech, said: "As one of Europe´s
largest and well respected life science partnering events, BIO-Europe
represents a valuable opportunity for us to raise our profile with
potential licensees and other commercial partners. We are looking
forward to participating at the conference alongside interesting and
diverse companies who will also be displaying their technologies, and
we are excited about the opportunities that the partnering meetings
will offer."